Modulation of biophysical properties of nucleocapsid protein in the mutant spectrum of SARS-CoV-2.
SARS-CoV-2
biophysical fitness landscape
genotype-phenotype relationship
infectious disease
intrinsically disordered protein
microbiology
molecular biophysics
mutant spectrum
protein evolution
structural biology
viruses
Journal
eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614
Informations de publication
Date de publication:
28 Jun 2024
28 Jun 2024
Historique:
medline:
28
6
2024
pubmed:
28
6
2024
entrez:
28
6
2024
Statut:
epublish
Résumé
Genetic diversity is a hallmark of RNA viruses and the basis for their evolutionary success. Taking advantage of the uniquely large genomic database of SARS-CoV-2, we examine the impact of mutations across the spectrum of viable amino acid sequences on the biophysical phenotypes of the highly expressed and multifunctional nucleocapsid protein. We find variation in the physicochemical parameters of its extended intrinsically disordered regions (IDRs) sufficient to allow local plasticity, but also observe functional constraints that similarly occur in related coronaviruses. In biophysical experiments with several N-protein species carrying mutations associated with major variants, we find that point mutations in the IDRs can have nonlocal impact and modulate thermodynamic stability, secondary structure, protein oligomeric state, particle formation, and liquid-liquid phase separation. In the Omicron variant, distant mutations in different IDRs have compensatory effects in shifting a delicate balance of interactions controlling protein assembly properties, and include the creation of a new protein-protein interaction interface in the N-terminal IDR through the defining P13L mutation. A picture emerges where genetic diversity is accompanied by significant variation in biophysical characteristics of functional N-protein species, in particular in the IDRs. Like other types of RNA viruses, the genetic material of SARS-CoV-2 (the agent responsible for COVID-19) is formed of an RNA molecule which is prone to accumulating mutations. This gives SARS-CoV-2 the ability to evolve quickly, and often to remain one step ahead of treatments. Understanding how these mutations shape the behavior of RNA viruses is therefore crucial to keep diseases such as COVID-19 under control. The gene that codes for the protein that ‘packages’ the genetic information inside SARS-CoV-2 is particularly prone to mutations. This nucleocapsid (N) protein participates in many key processes during the life cycle of the virus, including potentially interfering with the immune response. Exactly how the physical properties of the N-Protein are impacted by the mutations in its genetic sequence remains unclear. To investigate this question, Nguyen et al. predicted the various biophysical properties of different regions of the N-protein based on a computer-based analysis of SARS-CoV-2 genetic databases. This allowed them to determine if specific protein regions were positively or negatively charged in different mutants. The analyses showed that some domains exhibited great variability in their charge between protein variants – reflecting the fact that the corresponding genetic sequences showed high levels of plasticity. Other regions remained conserved, however, including across related coronaviruses. Nguyen et al. also conducted biochemical experiments on a range of N-proteins obtained from clinically relevant SARS-CoV-2 variants. Their results highlighted the importance of protein segments with no fixed three-dimensional structure. Mutations in the related sequences created high levels of variation in the physical properties of these ‘intrinsically disordered’ regions, which had wide-ranging consequences. Some of these genetic changes even gave individual N-proteins the ability to interact with each other in a completely new way. These results shed new light on the relationship between genetic mutations and the variable physical properties of RNA virus proteins. Nguyen et al. hope that this knowledge will eventually help to develop more effective treatments for viral infections.
Autres résumés
Type: plain-language-summary
(eng)
Like other types of RNA viruses, the genetic material of SARS-CoV-2 (the agent responsible for COVID-19) is formed of an RNA molecule which is prone to accumulating mutations. This gives SARS-CoV-2 the ability to evolve quickly, and often to remain one step ahead of treatments. Understanding how these mutations shape the behavior of RNA viruses is therefore crucial to keep diseases such as COVID-19 under control. The gene that codes for the protein that ‘packages’ the genetic information inside SARS-CoV-2 is particularly prone to mutations. This nucleocapsid (N) protein participates in many key processes during the life cycle of the virus, including potentially interfering with the immune response. Exactly how the physical properties of the N-Protein are impacted by the mutations in its genetic sequence remains unclear. To investigate this question, Nguyen et al. predicted the various biophysical properties of different regions of the N-protein based on a computer-based analysis of SARS-CoV-2 genetic databases. This allowed them to determine if specific protein regions were positively or negatively charged in different mutants. The analyses showed that some domains exhibited great variability in their charge between protein variants – reflecting the fact that the corresponding genetic sequences showed high levels of plasticity. Other regions remained conserved, however, including across related coronaviruses. Nguyen et al. also conducted biochemical experiments on a range of N-proteins obtained from clinically relevant SARS-CoV-2 variants. Their results highlighted the importance of protein segments with no fixed three-dimensional structure. Mutations in the related sequences created high levels of variation in the physical properties of these ‘intrinsically disordered’ regions, which had wide-ranging consequences. Some of these genetic changes even gave individual N-proteins the ability to interact with each other in a completely new way. These results shed new light on the relationship between genetic mutations and the variable physical properties of RNA virus proteins. Nguyen et al. hope that this knowledge will eventually help to develop more effective treatments for viral infections.
Identifiants
pubmed: 38941236
doi: 10.7554/eLife.94836
pii: 94836
doi:
pii:
Substances chimiques
Coronavirus Nucleocapsid Proteins
0
nucleocapsid phosphoprotein, SARS-CoV-2
0
Intrinsically Disordered Proteins
0
Phosphoproteins
0
Nucleocapsid Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIH HHS
ID : ZIA EB000099-02
Pays : United States
Déclaration de conflit d'intérêts
AN, HZ, DM, SS, DW, JC, GP, PS No competing interests declared
Références
Cell Rep. 2022 Aug 16;40(7):111212
pubmed: 35977510
Int J Mol Sci. 2020 Nov 28;21(23):
pubmed: 33260713
Evol Bioinform Online. 2015 Apr 29;11:85-96
pubmed: 25987828
Sci Adv. 2022 Aug 5;8(31):eabp9770
pubmed: 35921414
Protein Sci. 2012 Jun;21(6):769-85
pubmed: 22528593
Science. 2004 Jan 9;303(5655):186-95
pubmed: 14716003
Protein Sci. 2022 Apr;31(4):822-834
pubmed: 34984754
Int J Biol Macromol. 2021 Oct 1;188:391-403
pubmed: 34371045
Cell Rep. 2014 Jun 12;7(5):1729-1739
pubmed: 24882001
Nat Commun. 2021 Jan 21;12(1):502
pubmed: 33479198
J Virol. 2016 Apr 14;90(9):4357-4368
pubmed: 26889024
Proc Natl Acad Sci U S A. 2022 Jul 12;119(28):e2202222119
pubmed: 35787038
PLoS Pathog. 2022 Jun 21;18(6):e1010627
pubmed: 35728038
Mol Cell. 2020 Dec 17;80(6):1078-1091.e6
pubmed: 33290746
Biophys J. 2021 Jul 20;120(14):2890-2901
pubmed: 33794152
Proc Natl Acad Sci U S A. 2010 May 4;107(18):8183-8
pubmed: 20404210
Proc Natl Acad Sci U S A. 2021 Jul 20;118(29):
pubmed: 34292871
Protein Sci. 2016 Jul;25(7):1204-18
pubmed: 26833806
Virus Evol. 2021 Sep 02;7(2):veab073
pubmed: 34642604
Int J Infect Dis. 2022 Dec;125:231-232
pubmed: 36347459
Nature. 1986 Jan 16-22;319(6050):199-203
pubmed: 3945310
PLoS One. 2021 Jan 26;16(1):e0238665
pubmed: 33497392
Mol Biol Evol. 2010 Mar;27(3):609-21
pubmed: 19923193
Trends Biochem Sci. 2023 Dec;48(12):1019-1034
pubmed: 37657994
Science. 2009 Apr 10;324(5924):203-7
pubmed: 19359577
Nat Methods. 2022 Jun;19(6):679-682
pubmed: 35637307
Int J Mol Sci. 2023 May 22;24(10):
pubmed: 37240420
J Biol Chem. 2022 Nov;298(11):102560
pubmed: 36202211
Viruses. 2022 Sep 03;14(9):
pubmed: 36146764
Nature. 2022 Mar;603(7902):679-686
pubmed: 35042229
Chem Rev. 2022 Mar 23;122(6):6719-6748
pubmed: 35179885
Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):E1450-E1459
pubmed: 28167781
Virol J. 2023 Jan 10;20(1):6
pubmed: 36627683
Virus Evol. 2022 May 11;8(1):veac021
pubmed: 35573973
Biophys J. 2016 Jan 5;110(1):103-12
pubmed: 26745414
PLoS Biol. 2021 Oct 11;19(10):e3001425
pubmed: 34634033
J Mol Biol. 2022 May 15;434(9):167516
pubmed: 35240128
J Mol Biol. 2023 Aug 15;435(16):167955
pubmed: 36642156
PLoS Comput Biol. 2022 May 12;18(5):e1010121
pubmed: 35551296
Mol Biol Evol. 2018 Jan 1;35(1):38-49
pubmed: 29029259
Elife. 2021 Jan 25;10:
pubmed: 33491648
Nat Commun. 2020 Nov 27;11(1):6041
pubmed: 33247108
Future Virol. 2018 Jun;13(6):405-430
pubmed: 32201497
Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10167-72
pubmed: 8816770
Anal Biochem. 2013 Sep 1;440(1):81-95
pubmed: 23711724
iScience. 2021 Nov 19;24(11):103353
pubmed: 34729465
mBio. 2023 Nov 29;:e0238823
pubmed: 38018991
Mol Cell. 2020 Dec 17;80(6):1092-1103.e4
pubmed: 33248025
Protein Sci. 2021 Jan;30(1):70-82
pubmed: 32881101
Chem Rev. 2023 Jul 26;123(14):8945-8987
pubmed: 36881934
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Cell. 2020 Oct 29;183(3):730-738.e13
pubmed: 32979942
J Biol Chem. 2023 Dec;299(12):105362
pubmed: 37863261
Curr Opin Struct Biol. 2011 Jun;21(3):441-6
pubmed: 21482101
Elife. 2021 Dec 08;10:
pubmed: 34878407
iScience. 2021 Jun 25;24(6):102523
pubmed: 33997662
Sci Adv. 2022 Jan 21;8(3):eabm4034
pubmed: 35044811
Nature. 2021 Jan;589(7840):125-130
pubmed: 32906143
Curr Opin Struct Biol. 2014 Jun;26:84-91
pubmed: 24952216
Annu Rev Biophys. 2017 May 22;46:85-103
pubmed: 28301766
Mol Biol Evol. 2023 Apr 4;40(4):
pubmed: 37039557
Bioinformatics. 2015 Oct 15;31(20):3356-8
pubmed: 26069265
Multimed Tools Appl. 2023;82(9):14135-14152
pubmed: 36196269
Biophys Chem. 2022 Sep;288:106843
pubmed: 35696898
Pathog Immun. 2021 Aug 20;6(2):27-49
pubmed: 34541432
Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5869-74
pubmed: 16581913
Trends Biochem Sci. 2009 Feb;34(2):53-9
pubmed: 19062293
Virus Evol. 2023 Sep 18;9(2):vead055
pubmed: 37727875
J Clin Microbiol. 2020 Sep 22;58(10):
pubmed: 32690547
Virology. 2019 Nov;537:198-207
pubmed: 31505321
Cell. 2023 Mar 16;186(6):1263-1278.e20
pubmed: 36868218
ACS Cent Sci. 2023 Jul 24;9(8):1658-1669
pubmed: 37637734
Sci Signal. 2022 Oct 25;15(757):eabm0808
pubmed: 36282911
Nucleic Acids Res. 2024 Jun 24;52(11):6647-6661
pubmed: 38587193
Trends Microbiol. 1996 Jun;4(6):216-8
pubmed: 8795155
J Mol Biol. 2021 Jul 23;433(15):167108
pubmed: 34161778
Sci Transl Med. 2022 Aug 3;14(656):eabo0718
pubmed: 35482820
J R Soc Interface. 2014 Nov 6;11(100):20140419
pubmed: 25165599
Elife. 2021 Feb 22;10:
pubmed: 33616531
Appl Microbiol Biotechnol. 2022 Feb;106(3):1151-1164
pubmed: 35037999
Nucleic Acids Res. 1997 Sep 1;25(17):3389-402
pubmed: 9254694
Bioinformatics. 2007 May 1;23(9):1073-9
pubmed: 17332019
Cell. 2017 Mar 9;168(6):1028-1040.e19
pubmed: 28283059
Nucleic Acids Res. 2022 Aug 12;50(14):8168-8192
pubmed: 35871289
Cell Commun Signal. 2015 Feb 03;13:9
pubmed: 25644261
Curr Opin Struct Biol. 2017 Feb;42:31-40
pubmed: 27810574
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
PNAS Nexus. 2022 May 16;1(2):pgac049
pubmed: 35783502
Science. 2022 Jun 17;376(6599):1327-1332
pubmed: 35608456
Virus Res. 2020 Sep;286:198074
pubmed: 32589897
Science. 2021 Dec 24;374(6575):1626-1632
pubmed: 34735219
Annu Rev Microbiol. 1997;51:151-78
pubmed: 9343347
Trends Biochem Sci. 2011 Mar;36(3):159-69
pubmed: 21146412
PLoS Pathog. 2020 Dec 2;16(12):e1009100
pubmed: 33264373
Viruses. 2020 Dec 30;13(1):
pubmed: 33396605
Biochem Biophys Res Commun. 2021 Sep 10;569:154-160
pubmed: 34246830
Sci Adv. 2023 Apr 5;9(14):eadg6473
pubmed: 37018390
PLoS Pathog. 2014 Dec 11;10(12):e1004529
pubmed: 25502394
Nat Ecol Evol. 2017 Feb 21;1(3):77
pubmed: 28812721
J Biol Chem. 2017 Nov 17;292(46):19110-19120
pubmed: 28924037
Angew Chem Int Ed Engl. 2006 May 5;45(19):3022-60
pubmed: 16619322
PLoS One. 2015 May 21;10(5):e0126420
pubmed: 25997164
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
Nat Commun. 2021 Mar 29;12(1):1936
pubmed: 33782395
J Biol Chem. 2022 Mar;298(3):101677
pubmed: 35131265
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
Biomolecules. 2022 Jul 02;12(7):
pubmed: 35883485